Dexcom Inc.
DXCM
pitch
short
Marc Grow ’17, Benjamin Ostrow ’17, and Evan Zehnal ’17
Thesis
Dexcom Inc. is facing significant challenges in its market position and competitive landscape, which could lead to a decline in its stock price. The company's growth may not sustain at the current levels due to increasing competition and pricing pressures.
Did it work?
inconclusive
confidence: low
Without specific price performance data or a defined time frame since the pitch, it's unclear whether the thesis regarding Dexcom Inc.'s market challenges has materialized. The lack of information on the stock's performance prevents a definitive judgment on the success of the short thesis.
Raw excerpt
No raw excerpt stored.